James E. Francese is a notable inventor based in Anaheim, CA, who has made significant contributions to the field of ophthalmology. With a total of 5 patents to his name, Francese has focused on developing innovative solutions that enhance the protection of eye tissues during surgical procedures.

Latest Patents

Among his latest patents, Francese has developed bimodal molecular weight hyaluronate formulations and methods for their use. These compositions are designed to protect human or animal eye cell layers and tissues that may be exposed to trauma, particularly during surgery. The method involves administering an ophthalmically acceptable aqueous composition that contains two distinct fractions of alkali metal and/or alkaline earth metal hyaluronate. The first fraction has a molecular weight of at least about 2 million, while the second fraction ranges from about 200,000 to about 800,000. This innovative approach aims to safeguard eye tissues prior to exposure to potential trauma.

Career Highlights

James E. Francese is currently associated with Allergan, Inc., a company renowned for its advancements in eye care and other medical fields. His work at Allergan has allowed him to focus on developing cutting-edge solutions that address critical needs in ophthalmology.

Collaborations

Throughout his career, Francese has collaborated with esteemed colleagues, including F. Richard Christ and Bernard F. Grisoni. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

James E. Francese stands out as an influential inventor in the realm of ophthalmic solutions, with a commitment to enhancing the safety and effectiveness of eye surgeries. His innovative patents reflect his dedication to improving patient outcomes in the field of ophthalmology.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to [email protected]